Search results
vWF Deficient Plasma, congenital (Type 2A), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 2A) deficient plasma.
vWF Deficient Plasma, congenital (Type 1), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 1) deficient plasma.
Factor VIII Inhibitor Plasma congenital, frozen
For research use only.
Factor VIII deficient plasma congenital (frozen)
For all in-vitro -analyses that require congenital human factor VIII deficient plasma.
Factor VIII deficient plasma congenital, pooled (frozen)
For all in-vitro -analyses that require congenital pooled human factor VIII deficient plasma.
tPA Deficient Plasma
For all in-vitro -analyses that require human tPA deficient plasma.
NAPTT Reagent Kit
Liquid "ready for use", containing synthetic phospholipid blend. This kit is intended for use in the European Pharmacopoeia (EP) method for the detection of activated coagulation factors in therapeutic products. Also, the NAPTT reagent alone can be used in the NAPTT test for detecting contact activation and hypercoagulability (For Research Use Only).
Tris buffer - progressive AT - Anti Xa, pH 7.85
Dilution buffer for progressive antithrombin activity assay, using a variant protocol for BIOPHEN®Antithrombin kit (ref. 221102/221105).
Tris buffer - progressive AT - Anti IIa, pH 8.40
Dilution buffer for progressive antithrombin activity using an anti IIa method, and a variant protocol of BIOPHEN®AT (Anti IIa) kit (ref. 221122), performed in the absence of heparin.
BIOPHEN Heparin anti-IIa (Kinetics)
Assay proposed for the measurement of heparin in research applications.